title: Time for Glucagon like peptide-1 receptor agonists treatment for patients with NAFLD?
authors.affiliation: Institute of Clinical Physiology, CNR, Pisa, Italy. Electronic address: amalia@ifc.cnr.it.
authors.forename: Amalia
authors.initials: A
authors.lastname: Gastaldelli
authors.affiliation: Clinical Dietetics, "Alma Mater" University, Bologna, Italy.
authors.forename: Giulio
authors.initials: G
authors.lastname: Marchesini
mesh_terms: D003924:Diabetes Mellitus, Type 2; D052216:Glucagon-Like Peptide 1; D006801:Humans; D007004:Hypoglycemic Agents; D065626:Non-alcoholic Fatty Liver Disease / Q000188:drug therapy*; D010455:Peptides
chemical_list: D007004:Hypoglycemic Agents; D010455:Peptides; D052216:Glucagon-Like Peptide 1